National Pharmaceuticals Corp. is a pharmaceutical research and development company dedicated to leading edge technologies for treatment of human diseases. The company has focused its efforts on the business of licensing mid stage development drugs for further development and marketing worldwide.
The company’s lead therapeutic drug is believed to have significant effects on the management of pain due to trauma, wound, and accidents, as well as autoimmune conditions. Under the internal name GLB333, the cytokine functions differently than current pain killers or analgesics. It helps to rebuild the damage tissues, reduces inflammatory conditions and helps to regenerate good and healthy muscle and soft tissues.
Globe Laboratories has worked on the biology and use of GLB333 for several years and has invested considerable resources on its development. The company retains the worldwide exclusive license to the use and marketing of the product, although the license carries standard terms and conditions used by other companies in this sector.
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment